Nephros, Inc.
NEPH
$4.36
$0.307.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 15.45% | 10.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.45% | 10.21% | |||
| Cost of Revenue | -10.27% | 12.75% | |||
| Gross Profit | 34.51% | 8.40% | |||
| SG&A Expenses | -4.09% | 8.85% | |||
| Depreciation & Amortization | 0.00% | -9.38% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.08% | 8.58% | |||
| Operating Income | 1,150.52% | 438.89% | |||
| Income Before Tax | 764.29% | 125.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 755.00% | 125.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 755.00% | 125.81% | |||
| EBIT | 1,150.52% | 438.89% | |||
| EBITDA | 902.42% | 148.00% | |||
| EPS Basic | 741.98% | 125.86% | |||
| Normalized Basic EPS | 750.00% | 127.78% | |||
| EPS Diluted | 1,000.00% | 72.41% | |||
| Normalized Diluted EPS | 751.25% | 128.57% | |||
| Average Basic Shares Outstanding | 1.93% | 0.03% | |||
| Average Diluted Shares Outstanding | 1.11% | -1.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||